In situ expression of CD40, CD40L (CD154), IL-12, TNF-α IFN-γ and TGF-β1 in murine lungs during slowly progressive primary tuberculosis

Scandinavian Journal of Immunology

Volumn 58, Issue 3, 2003, Pages 327-334

  Mogga, S J ^a   Mustafa, T ^a   Sviland, L ^a,b   Nilsen, R ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; GAMMA INTERFERON; INTERLEUKIN 12; MYCOBACTERIUM ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BACTERIAL SURVIVAL; CELL ACTIVATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; FROZEN SECTION; IMMUNOHISTOCHEMISTRY; LUNG; LYMPHOCYTE; MACROPHAGE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIMARY TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, CD40; CD40 LIGAND; CROSSES, GENETIC; CYTOKINES; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; INTERLEUKIN-12; LUNG; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MYCOBACTERIUM TUBERCULOSIS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0042412314     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2003.01304.x     Document Type: Article

References (48)

1. Mustafa T, Phyu S, Nilsen R, Jonsson R, Bjune G. A mouse modal for slowly progressive primary tuberculosis. Scand J Immunol 1999;50:127-36.
2. Mustafa T, Phyu S, Nilsen R, Jonsson R, Bjune G. In-situ expression of cytokines and cellular phenotypes in the lungs of mice with slowly progressive primary tuberculosis. Scand J Immunol 2000;51:548-56.
3. Mustafa T, Phyu S, Nilsen R, Bjune G, Jonsson R. Increased expression of Fas ligand on Mycobacterium tuberculosis infected macrophages: a potential novel mechanism of immune evasion by Mycobacterium tuberculosis? Inflammation 1999;23:507-21.
4. Mogga SJ, Mustafa T, Sviland L, Nilsen R. Increased Bcl-2 and reduced Bax expression in infected macrophages in slowly progressive primary murine Mycobacterium tuberculosis infection. Scand J Immunol 2002;56:383-91.
5. Bermudez LE, Kaplan G. Recombinant cytokines for controlling mycobacterial infections. Trends Microbiol 1995;22:22-7.
6. Kaplan G, Freedman VH. The role of cytokines in the immune response to tuberculosis. Res Immunol 1996;147:565-72.
7. Flesch IE, Kaufmann SH. Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4 and tumour necrosis factor. Infect Immun 1990;58:2675-7.
8. Tsai WC, Tsai JJ, Chen CJ, Yen JH, Ou TT, Liu HW. Monocyte-derived cytokine-IL-12, TGF-beta 1 and TNF-alpha in patients with tuberculosis. Kaohsiung J Med Sci 2002;18:17-22.
9. Kashara K, Kobayashi K, Shikama Y et al. The role of monokines in granuloma formation in mice: The ability of interleukin 1 and tumour necrosis factor - alpha to induce lung granulomas. Clin Immunol Immunopathol 1989;51:419-25.
10. Ding A, Nathan CF, Graycar J, Derynck R, Stuehr DJ, Srimal S. Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma. J Immunol 1990;145:940-4.
11. Chantry D, Turner M, AbneyA, Feldman M. Modulation of cytokine production by transforming growth factor-β3. J Immunol 1989;142:429-300.
12. Czarniecki CW, Chiu HH, Wong GHW, McCabe SM, Palladino MA. Transforming growth factor-β1 modulates the expression of class II histocompatibility antigens on human cells. J Immunol 1998;140:4217-24.
13. Kehri JH, Wakefield LM, Roberts AB et al. Production of transforming growth factor-β by human T lymphocytes and its potential in regulation of T cell growth. J Exp Med 1986;163:1037-50.
14. Cella M, Scheidegger D, Palmer-Lemman K et al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T-T cell help via APC activation. J Exp Med 1996;184:747-52.
15. Snijders A, Kalinski P, Hilkens CM, Kapsenberg ML. High level IL-12 production by human dendritic cells requires two signals. Int Immunol 1998;10:1593-8.
16. Lui Y, Janeway CA Jr. Cells that present both specific ligand and co-stimulatory activity are the most efficient inducers of clonal expansion of normal CD4 T cells. Proc Natl Acad Sci USA 1992;89:3845-9.
17. Smith CA, Farrah T, Goodwin RG. The TNF receptor super family of cellular and viral proteins: activation, costimulation and death. Cell 1994;76:959-62.
18. Hollenbaugh D, Grosmaire LS, Kullas CD et al. A human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J 1992;11:4313-21.
19. Schonbeck U, Libby P. The CD40/CD40L receptor/ligand dyad. Cell Mol Life Sci 2001;58:4-43.
20. Essen D, Kikutani H, Gray D. CD40 ligand-transduces co-stimulation of T cells in the development of helper function. Nature 1995;378:620-3.
21. Afford SC, Ahmed Choudhury J, Randhawa S et al. CD40 activation-induced, Fas dependent apoptosis and NF-kappaB/AP-1 signalling in human intrahepatic biliary epithelial cells. FASEB J 2001;15:2345-54.
22. Jakobson E, Jonsson G, Bjorck P, Pauline S. Stimulation of CD40 in human bladder carcinoma cells inhibits anti-Fas/APO-1 (CD95)-induced apoptosis. Int J Cancer 1998;77:849-53.
23. Larkin R, Benjamin CD, Hsu YM, Li Q, Zukowski L, Silver RF. CD40 ligand (CD154) does not contribute to lymphocyte-mediated inhibition of virulent Mycobacterium tuberculosis within human monocytes. Infect Immun 2002;70:4716-20.
24. Campos-Neto A, Ovendale P, Bement T et al. CD40 ligand is not essential for the development of cell-mediated immunity and resistance to Mycobacterium tuberculosis. J Immunol 1998;160:2037-41.
25. Wiker HG, Harboe M, Bennedsen J, Closs O. The antigens of Mycobacterium tuberculosis, H37Rv, studied by crossed immunoelectrophoresis. Comparison with reference system for Mycobacterium bovis, BCG. Scand J Immunol 1998;27:223-39.
26. Soler P, Boussaud V, Moreau J et al. In-situ expression of B7 and CD40 costimulatory molecules by normal human lung macrophages and epithelioid cells in tuberculoid granulomas. Clin Exp Immunol 1999;116:332-9.
27. Kamanaka M, Yu P, Yasui T et al. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 1996;4:275-81.
28. Storz M, Zepter K, Kamarashev J, Dummer R, Burg G, Haffner AC. Coexpression of CD40 and CD40 ligand in cutaneous T-cell lymphoma (mycosis fungoides). Cancer Res 2001;61:452-4.
29. Armitage RJ, Maliszewski CR, Alderson MR, Grabstein KH, Spriggs MK, Fanslow WC. CD40L: a multi-functional ligand. Semin Immunol 1993;5:401-12.
30. Grewal IS, Flavell RA. The CD40 ligand. At the centre of the immune universe? Immunol Res 1997;16:59-70.
31. Subauste CS, Wessendrap M, Sorensen RU, Leiva LE. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxolasma gondii: patients with hyper IgM syndrome have defective type 1 immune response that can be restored by soluble CD40 ligand trimer. J Immunol 1999;162:6690-700.
32. Campbell KA, Ovendale PJ, Kennady MK, Fanslow WC, Reed SG, Maliszewski CR. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 1996;4:283-9.
33. Hayashi T, Rao SO, Meylan PR, Kornbluth RS, Catanzaro A. Role of CD40 ligand in Mycobacterium avium infection. Infect Immun 1999;7:3558-65.
34. Straw AD, MacDonald AS, Denkers EY, Pearce EJ. CD154 plays a central role in regulating dendritic cell activation during infections that induce Th1 or Th2 responses. J Immunol 2003;170:727-34.
35. Gao LY, Abu Kwaik Y. The mechanism of killing and exiting the protozoan host Acanthamoeba polyphaga by Legionella pneumophila. Environ Microbiol 2000;2:79-90.
36. Mendez-Samperio P, Garcia-Martinez E. CD40 ligand expression in Mycobacterium bovis BCG infection and its regulatory cytokines: a direct role of interleukin-12. Arch Med Res 2001;32:108-12.
37. Toosi Z, Gogate P, Shiratsuchi H, Young T, Ellner JJ. Enhanced production of TGF-β by blood monocytes from patients with active tuberculosis and presence of TGF-β in tuberculous granulomatous lung lesions. J Immunol 1995;154:465-73.
38. Hernandez-Pando R, Orozco H, Arriaga K, Sampieri A, Larriva-Sahd J, Madrid Marina V. Analysis of the local kinetics and localization of interleukin-1 alpha, tumour necrosis factor-alpha and transforming growth factor-beta, during the course of experimental pulmonary tuberculosis. Immunology 1997;90:607-17.
39. Espevik T, Figari IS, Shalaby MR et al. Inhibition of cytokine production by cyclosporin A and transforming growth factor-β. J Exp Med 1987;166:571-7.
40. Mendez-Samperio P, Hernandez-Garay M, Garcia-Martinez E. Induction of apoptosis in bacillus Calmette-Guerin-activated T cells by transforming growth factor-beta. Cell Immunol 2000;202:103-12.
41. Balcewicz-Sablinska MK, Keane J, Kornfeld H, Remold HG. Pathogenic Mycobacteria tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha. J Immunol 1998;161:2636-41.
42. Lømo J, Blomhoff HK, Jacobsen SE, Krajewski S, Reed JC, Smeland EB. Interleukin 13 in combination with CD40 ligand potently inhibits apoptosis in human B-lymphocytes: Upregulation of Bcl-xL and Mcl-1. Blood 1997;89:4415-24.
43. Lopez M, Sly LM, Luu Y, Young D, Cooper H, Reiner NE. The 19-kDa Mycobacterium tuberculosis protein induces macrophage apoptosis through Toll-like receptor-2. J Immunol 2003;170:2409-16.
44. An S, Knox KA. Ligation of CD40 rescues Ramos-Burkitt lymphoma cells from calcium ionphore- and antigen receptor-ligand apoptosis by inhibiting activation of the cysteine protease CPP32/Yama and cleavage of its substrate PARP. FEBS Lett 1996;386:115-22.
45. Sly LM, Hingley-Wilson SM, Reiner NE, McMaster WR. Survival of Mycobacterium tuberculosis in host macrophages involves resistance to apoptosis dependent upon induction of antiapoptotic Bcl-2 family member Mcl-1. J Immunol 2003;170:430-7.
46. Liu YJ, Johnsson GD, Gordon J, MacLennan IC. Germinal centres in T-cell-dependent antibody responses. Immunol Today 1992;13:13-21.
47. Foy TM, Aruffo A, Bajorath J, Buhlmann JE, Noelle RJ. Immune regulation by CD40 and its ligand GP39. Annu Rev Immunol 1996;14:91-617.
48. Ciaramella A, Cavone A, Santucci MB et al. Proinflammatory cytokines in the course of Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages. J Infect Dis 2002;186:1277-82.